data13F

RCKT – Rocket Pharmaceuticals Inc

Held by 1 of 60 tracked investors in their latest 13F filing · 0 counted on Most owned (narrow-view filings excluded)

Investors holding1
Combined shares50,493
Combined reported value$133K

RCKT chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Paul Tudor Jones narrow view 0.00 50,493$133KQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q1 2026Paul Tudor Jones narrow view Added 19.1%50,4930.00
Q4 2025Paul Tudor Jones narrow view Reduced 15.4%42,4110.00

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q1 2026Paul Tudor Jones narrow view Added 19.1%50,4930.00

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q4 2025Paul Tudor Jones narrow view Reduced 15.4%42,4110.00

History

1 peakQ3 2026: 1 tracked investors
Q1 2022: 1 tracked investorsQ2 2023: 1 tracked investorsQ3 2024: 1 tracked investorsQ4 2024: 1 tracked investorsQ1 2025: 1 tracked investorsQ2 2025: 1 tracked investorsQ3 2025: 1 tracked investorsQ4 2025: 1 tracked investorsQ1 2026: 1 tracked investorsQ2 2026: 1 tracked investorsQ3 2026: 1 tracked investors
20222026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Paul Tudor Jones50.5K50.5K50.5K42.4K50.1K50.2K50.1K31.1K

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).